
Melaleuca (t21) IgE
Quest Diagnostics
Sample type: Serum
Requires fasting: No
Phlebotomy required
Details
This test quantifies an individual’s IgE response to melaleuca. It is an in vitro quantitative assay, which is intended to be used in conjunction with other clinical information to aid in the diagnosis of allergic diseases.
- Melaleuca (t21) ige
Estimated days for results: Results should be available in 2 - 5 business days after the sample is collected
Melaleuca (t21) IgE
This test measures the IgE response to melaleuca, helping to identify allergic reactions. It's a quantitative assay used alongside other clinical data to assist in diagnosing allergic diseases. Allergen-specific serum IgE testing, recognized by leading allergy and immunology academies, may be preferred over skin testing in certain situations, such as widespread skin disease, recent antihistamine use, uncooperative patients, or when skin testing poses a significant allergy risk.
This test measures the IgE response to melaleuca, helping to identify allergic reactions. It's a quantitative assay used alongside other clinical data to assist in diagnosing allergic diseases. Allergen-specific serum IgE testing, recognized by leading allergy and immunology academies, may be preferred over skin testing in certain situations, such as widespread skin disease, recent antihistamine use, uncooperative patients, or when skin testing poses a significant allergy risk.
When is this test recommended?
Healthcare professionals might suggest this test if there's a suspicion of an allergy to melaleuca, especially under conditions that make skin testing unsuitable or risky.
What type of sample is required for this test?
0.3 mL serum.
Phlebotomy is required.
Phlebotomy is required.
Important Considerations:
A definitive allergy diagnosis should not rely solely on this test but should include a comprehensive evaluation by a trained healthcare professional of all clinical and laboratory findings.
Test Resources:
http://www.phadia.com/en/products/allergy-testing-products/immunocap-allergen-information/tree-pollens/allergens/melaleuca-cajeput-tree/
Reference:
http://www.phadia.com/en/products/allergy-testing-products/immunocap-allergen-information/tree-pollens/allergens/melaleuca-cajeput-tree/
Reference:
Bernstein IL, et al. Ann Allergy Asthma Immunol. 2008;100(suppl 3):S1-S148.
2–5 business days
Blood Draw Options with Fullscript
Fullscript offers several convenient phlebotomy options to complete your lab testing:
Quest Diagnostics Patient Service Centers (PSC)
- Location: Visit a nearby Quest Diagnostics Patient Service Center.
- Cost: $10 sample collection fee (paid during lab order checkout).
- Scheduling: Schedule your appointment here. Appointments are recommended to reduce wait times. Walk-ins are accepted, but may experience delays. Aim to arrive 10 minutes before your appointment.
- Collection Instructions:
- Bring a valid ID.
- Bring your digital or printed requisition form, available in the Labs tab of your Fullscript account.
- Check-in: Scan the QR code from your confirmation email or follow kiosk instructions.
- More Info: Quest Diagnostics blood draw guide
Getlabs Mobile Phlebotomy
- Location: Sample collection at your home or office.
- Cost: $85 sample collection fee (paid during lab order checkout).
- Availability: Available in most locations – enter your ZIP code during checkout to confirm.
- Scheduling: Schedule your appointment here through your Fullscript account.
- Collection Instructions:
- Have your digital or printed requisition form and valid ID ready.
- Your phlebotomist will contact you by phone to coordinate arrival.
- More Info: Getlabs blood draw guide
Specimen
- Preferred Specimen(s): 0.3 mL serum
- Alternative: NA
- Minimum Volume: 0.15 mL
- Collection Instructions: NA
Storage and shipping instructions
- Transport Container: Serum separator tube (SST)
- Transport Temperature: Room Temperature
- Specimen Stability:
- Room temperature: 14 days
- Refrigerated: 14 days
- Frozen: 30 days
- Reject Criteria: NA
State restrictions:
Patient can't order this test if they are located in Hawaii, Puerto Rico, New Jersey, New York, or Rhode Island




